Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 233-240

  Rose, R J ^a   Liu, H ^a   Palmer, D ^a   Maurice, D H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cyclic AMP; Cyclic nucleotide phosphodiesterase; Heterologous desensitization; Vascular smooth muscle cells

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 8 BROMO CYCLIC AMP; CILOSTAMIDE; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLOHEXIMIDE; DACTINOMYCIN; FORSKOLIN; ISOPRENALINE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL CELL; ARTICLE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENYLATE CYCLASE; ANIMALS; AORTA; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; FORSKOLIN; MUSCLE, SMOOTH, VASCULAR; RATS;

EID: 0030859498     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701376     Document Type: Article

References (36)

1. ALVAREZ, R., SETTE, C., YANG, D., EGLEN, R., WILHELM, R., SHELTON, E.R. & CONTI, M. (1995). Activation and selective inhibition of a cyclic-AMP-specific phosphodiesterase, PDE-4D3. Mol. Pharmacol., 48, 616-622.
2. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150-155.
3. BOLGER, G., MICHAELI, T., MARTINS, T., ST. JOHN, T., STEINER, B., RODGERS, L., RIGGS, M., WIGLER, M. & FERGUSON, K. (1993). A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol. Cell. Biol., 13, 6558-6571.
4. BOUSQUET-MÉLOU, A., GALITZKY, J., MORENO, C.M., BERLAN, M. & LAFONTAN, M. (1995). Desensitization of β-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase. Eur. J. Pharmacol., 289, 235-247.
5. BYLUND, D.B., EIKENBERG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO (JR), R.R. & TRENDELENBURG, U. (1994). International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev., 46, 121-136.
6. DAVIS, C.W. & DALY, J.W. (1979). A simple direct assay of 3′, 5′-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-boronate affinity gel chromatography. J. Cyclic Nucleotide Res., 5, 65-74.
7. DELPY, E., COSTE, H. & LE MONNIER DE GOUVILLE, A.-C. (1996). Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br. J. Pharmacol., 119, 471-478.
8. DICKINSON, N.T., JANG, E.K. & HASLAM, R.J. (1997). Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation. Biochem. J., 323, 371-377.
9. ELKS, M.L., MANGANIELLO, V.C. & VAUGHAN, M. (1983). Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. J. Biol. Chem., 258, 8582-8587.
10. GRANT, P.G. & COLMAN, R.W. (1984). Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry, 23, 1801-1807.
11. GRANT, P.G., MANNARINO, A.F. & COLMAN, R.W. (1988). cAMP-mediated phosphorylation of the low Km cAMP phosphodiesterase markedly stimulates its catalytic activity. Proc. Natl. Acad. Sci. U.S.A., 85, 9071-9075.
12. HAUSDORFF, W.P., CARON, M.G. & LEFKOWITZ, R.J. (1990). Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J., 4, 2881-2889.
13. LINCOLN, T.M. (1989). Cyclic GMP and mechanisms of vasodilation. Pharmacol. Ther., 41, 479-502.
14. LUGNIER, C., SCHOEFFTER, P., LE BEC, A., STROUTHOU, E. & STOCLET, J.C. (1986). Selective inhibition of cyclic nucleotide phosphodiesterascs of human, bovine and rat aorta. Biochem. Pharmacol., 35, 1743-1751.
15. MANGANIELLO, V.C., TAIRA, M., DEGERMAN, H. & BELFRAGE, P. (1995). Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell. Signal., 7, 445-455.
16. MANGANIELLO, V.C., TANEKA, T. & MURASHIMA, S. (1990). Cyclic GMP-stimulated cyclic nucleotide phosphodiesterases. In Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action. ed. Beavo, J. & Houslay, M.D. pp. 61-85. Chichester: Wiley.
17. MANNING, C.D., MCLAUGHLIN, M.M., LIVI, G.P., CIESLINSKI, L.B., TORPHY, T.J. & BARNETTE, M.S. (1996). Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J. Pharmacol. Exp. Ther., 276, 810-818.
18. MAURICE, D.H., CRANKSHAW, D. & HASLAM, R.J. (1991). Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle. Eur. J. Pharmacol., 192, 235-242.
19. MAURICE, D.H. & HASLAM, R.J. (1990a). Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol., 37, 671-681.
20. MAURICE, D.H. & HASLAM, R.J. (1990b). Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle. Eur. J. Pharmacol., 191, 471-475.
21. MAURICE, D.H., LEE, R.M.K.W. & HASLAM, R.J. (1993). Measurement of both cyclic [3H]AMP and cyclic [3H]GMP in cultured vascular smooth muscle cells labeled with [3H]hypoxanthine: Use in studies of cardiovascular drugs. Anal. Biochem., 215, 110-117.
22. MAURICE, D.H., SENIS, Y.A., LIU, H., GILES, A.R. & HORN, E.H. (1995). Cell layer-specific expression of cyclic nucleotide phosphodiesterases in rat arteries: Molecular cloning using isolated cell layers from paraformaldehyde-fixed tissues. J. Pharmacol. Toxicol. Meth., 34, 175-185.
23. MCDONALD, L.J. & MURAD, F. (1996). Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med., 211, 1-6.
24. MURRAY, K.J. (1990). Cyclic AMP and mechanisms of vasodilation. Pharmacol. Ther., 47, 329-345.
25. PANG, S.C. & VENANCE, S.L. (1992). Cultured smooth muscle approach in the study of hypertension. Can. J. Physiol. Pharmacol., 70, 573-579.
26. PERKINS, J.P., HAUSDORF, W.P. & LEFKOWITZ, R.J. (1991). Mechanisms of ligand-induced desensitization of beta-adrenergic receptors. In The β-adrenergic Receptors, ed. Perkins J.P., pp. 73-87, NJ: Humana Press.
27. RAHN, T., RÖNNSTRAND, L., LEROY, M.-J., WERNSTEDT, C., TORNQVIST, H., MANGANIELLO, V.C., BELFRAGE, P. & DEGERMAN, E. (1996). Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproternol. J. Biol. Chem., 271, 11575-11580.
28. SCHOEFFTER, P., LUGNIER, C., DEMESY-WAELDELE, F. & STOCLET, J.C. (1987). Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem. Pharmacol., 36, 3965-3972.
29. SETTE, C. & CONTI, M. (1996). Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem., 271, 16526-16534.
30. SETTE, C., IONA, S. & CONTI, M. (1994). The short-term activation of a rolipram sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by acAMP-dependent phosphorylation. J. Biol. Chem., 269, 9245-9252.
31. SUNAHARA, R.K., DESSAUER, C.W. & GILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol., 36, 461-480.
32. SWINNEN, J.V., JOSEPH, D.R. & CONTI, M. (1989). The mRNA encoding a high affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc. Natl. Acad. Sci. U.S.A., 86, 8197-8201.
33. TORPHY, T.J., ZHOU, H.-L. & CIESLINSKI, L.B. (1992). Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther., 263, 1195-1205.
34. TORPHY, T.J., ZHOU, H.-L., FOLEY, J.J., SARAU, H.M., MANNING, C.D. & BARNETTE, M.S. (1995). Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. J. Biol. Chem., 270, 23598-23604.
35. VERGHESE, M.W., MCCONNELL, R.T., LENHARD, J.M., HAMACHER, L. & JIN, S.-L.C. (1995). Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmacol., 47, 1164-1171.
36. WEISHAAR, R.E., BURROWS, S.D., KOBYLARZ, D.C., QUADE, M.M. & EVANS, D.B. (1986). Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase and cardiotonic agents. Biochem. Pharmacol., 35, 787-800.